Outlook Therapeutics (OTLK) Q2 2026 Earnings

14MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.44
-0.31
-0.19
-0.06

Details

Expected EPS
-0.121167
Actual EPS
N/A
Surprise EPS
0.12
Surprise Percent
+100%

Description

Outlook Therapeutics (OTLK) will report earnings of for Q2 2026 on May 14, 2026.

0 Comments

Share your thoughts